Absci (ABSI) financial statements

Healthcare · Biotechnology · Market cap $1.5B

Absci reported revenue of $3M in fiscal 2025, down 7.4% a year over 5 years.

Net income was -$115M and the operating margin -4297.0%, against -323.1% in 2020.

Free cash flow was -$94M.

The diluted share count rose 783% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.1-0.100.1202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Absci's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Revenue$4M$4M$5M$6M$5M$3M
Research and development$11M$45M$59M$48M$64M$81M
Selling, general and admin$6M$29M$41M$38M$36M$35M
Operating income-$13M-$75M-$107M-$116M-$109M-$120M
Interest expense$634,000$3M$972,000$1M$565,000$209,000
Pre-tax income-$14M-$110M-$105M-$110M-$103M-$115M
Income tax$0-$9M-$461,000$100,000$70,000$69,000
Net income-$14M-$101M-$105M-$111M-$103M-$115M
EPS (diluted)-$3.19-$2.08-$1.15-$1.20-$0.94-$0.84
Diluted shares15M50M91M92M110M137M
Operating margin-323.1%-1876.7%-2357.0%-2020.2%-2401.6%-4297.0%
Net margin-348.6%-2518.3%-2316.3%-1933.6%-2274.1%-4113.7%

Balance sheet

Fiscal years, from Absci's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Cash and short-term investments$70M$253M$60M$72M$112M$144M
Receivables———$2M$0—
Total current assets$73M$273M$187M$121M$134M$150M
Property, plant and equipment$9M$52M$53M$41M$29M$21M
Goodwill$0$21M$21M$0——
Total assets$89M$426M$321M$217M$214M$216M
Total current liabilities$10M$34M$30M$30M$29M$23M
Total liabilities$22M$60M$47M$41M$34M$27M
Shareholders' equity-$89M$366M$274M$176M$179M$189M
Net debt-$70M-$253M-$60M-$72M-$41M-$20M

Cash flow

Fiscal years, from Absci's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Operating cash flow-$11M-$61M-$81M-$65M-$72M-$93M
Capital spending$2M$38M$16M$860,000$404,000$1M
Free cash flow-$13M-$99M-$98M-$65M-$73M-$94M
Stock-based compensation$420,000$11M$13M$11M$19M$18M
Net borrowing-$500,000-$2M-$5M-$3M-$3M-$3M
Free cash flow margin-319.4%-2460.6%-2153.1%-1145.4%-1605.8%-3358.3%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ABSI.
Open ABSI in Investingly

Questions

What was Absci's revenue in 2025?

$3M in fiscal 2025, from its 10-K filing.

How much free cash flow does Absci generate?

-$94M in fiscal 2025 (operating cash flow minus capital spending).

From Absci's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.